Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
- July -
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
- 2021 -
2022
-
2023
-
2024
-
2025
July 2021 - 42 products
L
IP
CI
Posaconazol Viatris 40
mg/ml
105 ml
513.14
574.50
10 %
Suspension (oral): Posaconazolum 200mg / 5ml
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Ezetimib-Rosuvastatin
Viatris 10 mg / 10 mg
30
21.68
40.00
10 %
Coated tablets: 2 Active Agents
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
Ezetimib-Rosuvastatin
Viatris 10 mg / 10 mg
90
65.05
87.15
10 %
Coated tablets: 2 Active Agents
Viatris Pharma GmbH
B / SL
FB
G
L
IP
Ezetimib-Rosuvastatin
Viatris 10 mg / 20 mg
30
24.96
43.55
10 %
Coated tablets: 2 Active Agents
Viatris Pharma GmbH
B / SL
FB
G
L
IP
Ezetimib-Rosuvastatin
Viatris 10 mg / 20 mg
90
74.88
97.85
10 %
Coated tablets: 2 Active Agents
Viatris Pharma GmbH
B / SL
FB
G
L
IP
V/S
Efluelda 0.7 ml
31.00
48.80
10 %
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
IP
CI
Nepexto 50 mg/1 ml
2
PR
PR
k.A.
Medius AG
B
FB
G
IP
CI
Nepexto 50 mg/1 ml
2
PR
PR
k.A.
Medius AG
B
FB
G
IP
V/S
Efluelda 0.7 ml
PR
PR
k.A.
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Efluelda 0.7 ml
5
PR
PR
k.A.
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Efluelda 0.7 ml
5
PR
PR
k.A.
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Efluelda 0.7 ml
10
PR
PR
k.A.
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Efluelda 0.7 ml
10
PR
PR
k.A.
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B
FB
G
L
IP
Cabazitaxel Accord 60
mg/3 ml
2447.84
2690.90
10 %
Concentrate for infusion: Cabazitaxelum 60 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Perindopril Amlodipin
Indapamid Zentiva 4 mg/5
mg/1.25 mg
30
16.73
34.60
10 %
Tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Perindopril Amlodipin
Indapamid Zentiva 4 mg/5
mg/1.25 mg
90
42.65
62.75
10 %
Tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Perindopril Amlodipin
Indapamid Zentiva 4 mg/10
mg/1.25 mg
30
16.73
34.60
10 %
Tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Perindopril Amlodipin
Indapamid Zentiva 4 mg/10
mg/1.25 mg
90
42.65
62.75
10 %
Tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Perindopril Amlodipin
Indapamid Zentiva 8 mg/5
mg/2.5 mg
30
16.73
34.60
10 %
Tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Perindopril Amlodipin
Indapamid Zentiva 8 mg/5
mg/2.5 mg
90
42.65
62.75
10 %
Tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Perindopril Amlodipin
Indapamid Zentiva 8 mg/10
mg/2.5 mg
30
16.73
34.60
10 %
Tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Perindopril Amlodipin
Indapamid Zentiva 8 mg/10
mg/2.5 mg
90
42.65
62.75
10 %
Tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Pemazyre 4,5 mg
14
6644.07
7124.60
10 %
Tablets: Pemigatinibum 4.5 mg
Incyte Biosciences
International Sàrl
A / SL
FB
G
L
IP
Pemazyre 9 mg
14
6644.07
7124.60
10 %
Tablets: Pemigatinibum 9 mg
Incyte Biosciences
International Sàrl
A / SL
FB
G
L
IP
Pemazyre 13,5 mg
14
6644.07
7124.60
10 %
Tablets: Pemigatinibum 13.5 mg
Incyte Biosciences
International Sàrl
A / SL
FB
G
L
IP
CI
Skyrizi 150mg
3085.45
3372.05
10 %
Injektionslösung im Fertigpen: Risankizumabum 150 mg/ml
AbbVie AG
B / SL
FB
G
L
IP
Herzuma 150 mg
456.84
513.25
10 %
poudre pour solution à diluer pour perfusion: Trastuzumabum 150 mg
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
Herzuma 440 mg
1335.64
1469.00
10 %
poudre pour solution à diluer pour perfusion: Trastuzumabum 440 mg
iQone Healthcare
Switzerland SA
A / SL
FB
G
IP
CI
Nepexto 50 mg/1 ml
4
PR
PR
k.A.
Medius AG
B
FB
G
IP
Nepexto 25 mg/0.5 ml
4
PR
PR
k.A.
Medius AG
B
FB
G
IP
CI
Nepexto 50 mg/1 ml
4
PR
PR
k.A.
Medius AG
B
FB
G
IP
CI
CM
Claragine
20
PR
PR
k.A.
Coated tablets: Petasitidis Folii Extractum Carbonei Dioxido 17.8-40 mg
Bayer (Schweiz) AG
D
FB
G
IP
CI
Dienogest Mylan 2 mg
28
39.48
61.70
k.A.
Tablets: Dienogestum 2 mg
Exeltis Suisse SA
B
FB
G
IP
CI
Dienogest Mylan 2 mg
84
100.67
131.95
k.A.
Tablets: Dienogestum 2 mg
Exeltis Suisse SA
B
FB
G
IP
CI
Pemazyre 4,5 mg
28
PR
PR
k.A.
Tablets: Pemigatinibum 4.5 mg
Incyte Biosciences
International Sàrl
A
FB
G
IP
Pemazyre 9 mg
28
PR
PR
k.A.
Tablets: Pemigatinibum 9 mg
Incyte Biosciences
International Sàrl
A
FB
G
IP
Pemazyre 13,5 mg
28
PR
PR
k.A.
Tablets: Pemigatinibum 13.5 mg
Incyte Biosciences
International Sàrl
A
FB
G
IP
Vaborem 1g/1g
6
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: 2 Active Agents
A. Menarini GmbH
A
FB
G
IP
CI
Kadefemin Mycostop 200 mg / 2%
PR
PR
k.A.
Vaginaltabletten und Creme: Clotrimazolum 200 mg
Vaginaltabletten und Creme: Clotrimazolum 20 mg
Max Zeller Söhne AG
D
FB
G
IP
CI
Amoxidin Plus 625 mg
20
PR
PR
k.A.
compresse rivestite con film: 2 Active Agents
Lagap SA
A
FB
G
IP
CI
Amoxidin Plus 1 g
10
PR
PR
k.A.
compresse rivestite con film: 2 Active Agents
Lagap SA
A
FB
G
IP
Amoxidin Plus 1 g
14
PR
PR
k.A.
compresse rivestite con film: 2 Active Agents
Lagap SA
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home